Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice

Biotechnology and Bioengineering
Mejdi NajjarAlice A Tomei

Abstract

With a view toward reduction of graft loss, we explored pancreatic islet transplantation within fibrin matrices rendered pro-angiogenic by incorporation of minimal doses of vascular endothelial growth factor-A165 and platelet-derived growth factor-BB presented complexed to a fibrin-bound integrin-binding fibronectin domain. Engineered matrices allowed for extended release of pro-angiogenic factors and for their synergistic signaling with extracellular matrix-binding domains in the post-transplant period. Aprotinin addition delayed matrix degradation and prolonged pro-angiogenic factor availability within the graft. Both subcutaneous (SC) and epididymal fat pad (EFP) sites were evaluated. We show that in the SC site, diabetes reversal in mice transplanted with 1,000 IEQ of syngeneic islets was not observed for islets transplanted alone, while engineered matrices resulted in a diabetes median reversal time (MDRT) of 38 days. In the EFP site, the MDRT with 250 IEQ of syngeneic islets within the engineered matrices was 24 days versus 86 days for islets transplanted alone. Improved function of engineered grafts was associated with enhanced and earlier (by day 7) angiogenesis. Our findings show that by engineering the transplant site...Continue Reading

References

Jul 1, 1995·Cell Transplantation·C K Colton
Jun 15, 1996·Transplantation·J H JuangG C Weir
Jul 11, 2002·Diabetologia·L Jansson, P-O Carlsson
Mar 5, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Tatsuya KinRay V Rajotte
Sep 16, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Stephanie M GustavsonAlan D Cherrington
Nov 22, 2005·Transplantation Proceedings·J-H JuangC-H Kuo
Nov 24, 2005·American Journal of Physiology. Endocrinology and Metabolism·R R MacGregorL Stehno-Bittel
Aug 28, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·S T M NillesenT H van Kuppevelt
Jan 13, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D M BermanNorma S Kenyon
Jan 31, 2009·Cell Transplantation·Dirk J van der WindtDavid K C Cooper
Jun 30, 2009·Tissue Engineering. Part a·Alan J HusseySandra J Feeney
Jul 30, 2009·Diabetes Care·Davide MineoCamillo Ricordi
Oct 2, 2009·Diabetes·David M HarlanUNKNOWN Immunology of Diabetes Society
Feb 2, 2010·Journal of Korean Medical Science·Hyoung-Il KimSang-Joon Kim
Jul 29, 2010·Current Diabetes Reports·Amer Rajab
Jul 31, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mikaël M Martino, Jeffrey A Hubbell
Aug 18, 2010·Transplantation·Anjali GolocheikineThalachallour Mohanakumar
Jun 23, 2011·Experimental Dermatology·Sabine A Eming, Jeffrey A Hubbell
Jul 27, 2011·Current Diabetes Reports·Elisa Cantarelli, Lorenzo Piemonti
Sep 16, 2011·Science Translational Medicine·Mikaël M MartinoJeffrey A Hubbell
Nov 10, 2011·Current Opinion in Organ Transplantation·A M James Shapiro
Mar 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Barbara LudwigUriel Barkai
Jun 1, 2012·Current Opinion in Endocrinology, Diabetes, and Obesity·Ronald G Gill, Nicholas H Bishop
Jul 6, 2012·Current Diabetes Reports·Michael R Rickels
Jul 18, 2012·Seminars in Pediatric Surgery·Paul R V Johnson, Katherine E Jones

❮ Previous
Next ❯

Citations

Jul 15, 2015·Expert Opinion on Biological Therapy·Alice Anna TomeiCamillo Ricordi
Aug 2, 2015·International Journal of Biological Macromolecules·Ejaj AhmadMohammed Saleemuddin
Jul 21, 2015·Tissue Engineering. Part B, Reviews·Daniel T BowersKenneth L Brayman
May 20, 2018·Biotechnology and Bioengineering·Kai-Chiang YangShoichiro Sumi
Aug 26, 2018·Biotechnology and Bioengineering·Marcos Perez-BasterrecheaAlvaro J Obaya
Feb 8, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Fanny LebretonEkaterine Berishvili
Mar 22, 2020·Transplant International : Official Journal of the European Society for Organ Transplantation·Hirotake KomatsuYoko Mullen
Nov 14, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Alexander Ulrich ErnstMinglin Ma
Dec 23, 2016·Nature Reviews. Drug Discovery·Tejal Desai, Lonnie D Shea
Oct 27, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Vita ManzoliAlice A Tomei
Apr 24, 2020·Science Translational Medicine·Kristina G MaxwellJeffrey R Millman
Jun 20, 2019·Frontiers in Bioengineering and Biotechnology·Shuixan Hu, Paul de Vos
Oct 8, 2020·Cell Transplantation·M Rezaa MohammadiJonathan Rt Lakey
Jul 16, 2021·Journal of Tissue Engineering·Edward X HanLaura E Niklason
Sep 5, 2021·Advanced Healthcare Materials·Siying WuJun Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.